Blood pressure drug may stop cocaine, alcohol addiction

New York, June 24 (IANS) Giving hopes to millions of addicts around the world, a drug helpful in treating high blood pressure is now effective in ceasing cocaine and alcohol addiction in animal models, new research says.

If the treatment is proven effective in humans, the drug called isradipine would be the first of its kind – one that could help prevent relapses – by erasing the unconscious memories that underlie addiction, the study said.

“This drug might help the addicted brain become de-addicted,” said lead researcher Hitoshi Morikawa, associate professor of neuroscience at The University of Texas at Austin.

For the study, the researchers trained rats to associate either a black or white room with the use of a drug.

Subsequently, when the addicted rats were offered the choice of going into either room, they nearly always chose the room they associated with their addiction.

Then one day, the researchers gave the addicted rats a high dose of an anti-hypertensive drug called isradipine before the rats made their choices.

Although rats still preferred the room they associated with their addiction on that day, they no longer showed a preference for it on subsequent days.

“The isradipine erased memories that led them to associate a certain room with cocaine or alcohol,” Morikawa said.

Addictive drugs are thought to rewire brain circuits involved in reward learning, forming powerful memories of drug-related cues.

Anti-hypertensive drugs all block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells.

The researchers found that blocking these ion channels in brain cells, using isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places.

Morikawa said that because isradipine is already labelled as safe for human use by the U.S. Food and Drug Administration (FDA), clinical trials could potentially be carried out much more quickly than with non-approved drugs.

The research was published in the journal Molecular Psychiatry.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here